| For: | Abbas Z, Afzal R. Life cycle and pathogenesis of hepatitis D virus: A review. World J Hepatol 2013; 5(12): 666-675 [PMID: 24409335 DOI: 10.4254/wjh.v5.i12.666] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v5/i12/666.htm |
| Number | Citing Articles |
| 1 |
Laura Iulia Grecu, Mariana Pavel-Tanasa, Lilia Matei, Camelia Sultana, Simona Maria Ruta, Razvan Ioan Grecu, Ramona Gabriela Ursu, Petru Cianga, Luminita Smaranda Iancu. Molecular Epidemiology of Hepatitis D Virus in the North-East Region of Romania. Pathogens 2024; 13(9) doi: 10.3390/pathogens13090793
|
| 2 |
Biology of T Cells - Part B. International Review of Cell and Molecular Biology 2019; 342 doi: 10.1016/bs.ircmb.2018.07.006
|
| 3 |
Abolfazl Jafarı-sales, Parniya Nouri-dizaj, Soheyla Hosseyni-nasababad, Sanam Karzar-torkambour, Aylin Golestani, Zahra Ghahremani, Mehrdad Pashazadeh, Sara Naebi. Hepatitis C Virus (HCV) and Hepatitis D Virus (HDV): Divergent Pathways to Hepatocellular Carcinoma (HCC) and Therapeutic Strategies. Archives of Current Medical Research 2026; 7(1) doi: 10.47482/acmr.1714274
|
| 4 |
F. Fatehi Chenar, Y.N. Kyrychko, K.B. Blyuss. Mathematical model of immune response to hepatitis B. Journal of Theoretical Biology 2018; 447 doi: 10.1016/j.jtbi.2018.03.025
|
| 5 |
Aiman Ghufran. Gastrointestinal and Liver Disorders in Women’s Health. 2019; doi: 10.1007/978-3-030-25626-5_17
|
| 6 |
Castine Bernardy, James Malley. Impacts of Surface Characteristics and Dew Point on the Blue-Light (BL405) Inactivation of Viruses. Microorganisms 2023; 11(11) doi: 10.3390/microorganisms11112638
|
| 7 |
George Sarin Zacharia, Anu Jacob. Pharmacotherapy of hepatitis D: the current and the future. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.100573
|
| 8 |
Elena Shirokova, Irina Efremova, Vladimir Ivashkin, Roman Maslennikov. Immune disorders and rheumatologic manifestations of viral hepatitis. World Journal of Gastroenterology 2021; 27(18): 2073-2089 doi: 10.3748/wjg.v27.i18.2073
|
| 9 |
Megan M. Xue, Jeffrey S. Glenn, Daniel H. Leung. Hepatitis D in Children. Journal of Pediatric Gastroenterology and Nutrition 2015; 61(3) doi: 10.1097/MPG.0000000000000859
|
| 10 |
Nehna Abdul Majeed, Asif A. Hitawala, Theo Heller, Christopher Koh. Diagnosis of HDV: From virology to non‐invasive markers of fibrosis. Liver International 2023; 43(S1) doi: 10.1111/liv.15515
|
| 11 |
Yating Xiao, Zhirui Tian, Jie Cui, Xia Yang, Dong Wang, Yangyang Cai, Qian Wu, Yaxin Jin, Hua Chen, Kai Ji. Natural Alkaloids Against Liver Injury: Mechanistic Insights and Multi-Target Therapeutic Potential. Biomolecules 2026; 16(6) doi: 10.3390/biom16060815
|
| 12 |
Rodrigo A. Villanueva, Alejandra Loyola. Pre- and Post-Transcriptional Control of HBV Gene Expression: The Road Traveled towards the New Paradigm of HBx, Its Isoforms, and Their Diverse Functions. Biomedicines 2023; 11(6) doi: 10.3390/biomedicines11061674
|
| 13 |
Megan S. McAfee, Trung P. Huynh, John L. Johnson, Bertram L. Jacobs, Joseph N. Blattman. Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunity. Virology 2015; 484 doi: 10.1016/j.virol.2015.05.021
|
| 14 |
Keisha R. Barton, Daniel H. Leung. Viral Hepatitis in Children. 2019; doi: 10.1007/978-981-13-0050-9_13
|
| 15 |
Eugene V Koonin, Benjamin D Lee. Diversity and evolution of viroids and viroid-like agents with circular RNA genomes revealed by metatranscriptome mining. Nucleic Acids Research 2025; 53(3) doi: 10.1093/nar/gkae1278
|
| 16 |
Ruby Dhiman, Gajala Deethamvali Ghousepeer, Ramendra Pati Pandey. Viral Hepatitis. 2026; doi: 10.1016/B978-0-443-29005-3.00007-1
|
| 17 |
Ahmet Gurakar, Ramzan Idilman, Peng-Sheng Ting, Muhammad Baraa Hammami, Aniqa Tehreem, Haris Muhammad. Hepatitis D virus and liver transplantation: Indications and outcomes. World Journal of Hepatology 2021; 13(3): 291-299 doi: 10.4254/wjh.v13.i3.291
|
| 18 |
Taravt Bamdad, Atefeh Yari. Encyclopedia of Infection and Immunity. 2022; doi: 10.1016/B978-0-12-818731-9.00078-1
|
| 19 |
S. F. Galimova. Chronic hepatitis D. Dokazatel'naya gastroenterologiya 2015; 4(4) doi: 10.17116/dokgastro201543-432-42
|
| 20 |
Ibrahim Halil Bahcecioglu, Abdurrahman Sahin. Treatment of Delta Hepatitis: Today and in the Future - A review. Infectious Diseases 2017; 49(4) doi: 10.1080/23744235.2016.1271998
|
| 21 |
Melissa Montoya-Guzmán, Carolina Posada-Álvarez, Laura Camila Lopera-Restrepo, Diana di Filippo-Villa, María-Cristina Navas. Infección por el virus de la hepatitis delta. Hepatología 2020; doi: 10.52784/27112330.120
|
| 22 |
Abdulmajeed A. Albarrak, Ky-Dieu Tran, Veysel Tahan. Viral Hepatitis: Chronic Hepatitis B. 2018; doi: 10.1007/978-3-319-93449-5_8
|
| 23 |
Kathryn Olsen, Sara Mahgoub, Sarah Al-Shakhshir, Akram Algieder, Sowsan Atabani, Ayman Bannaga, Ahmed M Elsharkawy. Recent treatment advances and practical management of hepatitis D virus. Clinical Medicine 2023; 23(4) doi: 10.7861/clinmed.2022-0556
|
| 24 |
Saurav Sarkar, Prajna Gupta, Gouranga Nandi, Ranabir Sahu, Paramita Paul, Tarun Kumar Dua, Sreejan Manna. The Role of Nutraceuticals in Degenerative Diseases (Part 2). 2026; doi: 10.2174/9798898813369126010008
|
| 25 |
Yang Yang, Marie-Laure Fogeron, Alexander A. Malär, Lauriane Lecoq, Alexander B. Barnes, Beat H. Meier, Anja Böckmann, Morgane Callon. Hepatitis Delta Antigen Retains the Assembly Domain as the Only Rigid Entity. Journal of the American Chemical Society 2024; 146(43) doi: 10.1021/jacs.4c09409
|
| 26 |
Nikhil Sharma, Sunit K. Singh. Implications of non‐coding RNAs in viral infections. Reviews in Medical Virology 2016; 26(5) doi: 10.1002/rmv.1893
|
| 27 |
Denitsa Tsaneva-Damyanova, Zhivka Stoykova, Irina Ivanova, Tsvetelina Kostadinova, Liliya Ivanova. Hepatitis D virus in Bulgaria: virology, epidemiology and pathogenesis in chronic HBV carriers with liver dysfunction. Scripta Scientifica Medica 2020; 52(3) doi: 10.14748/ssm.v52i3.6610
|
| 28 |
Joy Void-Holmes, Deborah Cartee. Infection Control in the Dental Office in the Era of COVID-19. 2024; doi: 10.1007/978-3-031-64611-9_3
|
| 29 |
Zehong Huang, Tingyu Peng, Zirui Li, Guoliang Zhu, Zixiang Zhu. Mechanistic insights into viral−host interactions during transcription. Biophysics Reports 2026; 12 doi: 10.52601/bpr.2026.250066
|
| 30 |
Minaam Abbas, Zaigham Abbas. Management of hepatitis delta: Need for novel therapeutic options. World Journal of Gastroenterology 2015; 21(32): 9461-9465 doi: 10.3748/wjg.v21.i32.9461
|
| 31 |
Diana Asema Asandem, Selorm Philip Segbefia, Kwadwo Asamoah Kusi, Joseph Humphrey Kofi Bonney. Hepatitis B Virus Infection: A Mini Review. Viruses 2024; 16(5) doi: 10.3390/v16050724
|
| 32 |
Zaigham Abbas, Syed Salman Ali, Lubna Shazi. Interferon alpha versus any other drug for chronic hepatitis D. Cochrane Database of Systematic Reviews 2015; doi: 10.1002/14651858.CD011727
|
| 33 |
|
| 34 |
Xin Ye, Chise Tateno, Emily P. Thi, Masakazu Kakuni, Nicholas M. Snead, Yuji Ishida, Trisha R. Barnard, Michael J. Sofia, Takashi Shimada, Amy C. H. Lee. Hepatitis B Virus Therapeutic Agent ARB-1740 Has Inhibitory Effect on Hepatitis Delta Virus in a New Dually-Infected Humanized Mouse Model. ACS Infectious Diseases 2019; 5(5) doi: 10.1021/acsinfecdis.8b00192
|
| 35 |
|
| 36 |
Erika Lasda, Roy Parker. Circular RNAs: diversity of form and function. RNA 2014; 20(12) doi: 10.1261/rna.047126.114
|
| 37 |
Brian Pearlman. Hepatitis Delta Infection: A Clinical Review. Seminars in Liver Disease 2023; 43(03) doi: 10.1055/a-2133-8614
|
| 38 |
Ben L Da, Theo Heller, Christopher Koh. Hepatitis D infection: from initial discovery to current investigational therapies. Gastroenterology Report 2019; 7(4) doi: 10.1093/gastro/goz023
|
| 39 |
Dowluru S.V.G.K. Kaladhar, Tantravahi Srinivasan. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; doi: 10.1016/B978-0-323-98806-3.00005-2
|
| 40 |
Mianzhi Chen, Dan Du, Wen Zheng, Mingheng Liao, Lu Zhang, Ge Liang, Meng Gong. Small hepatitis delta antigen selectively binds to target mRNA in hepatic cells: a potential mechanism by which hepatitis D virus downregulates glutathione S-transferase P1 and induces liver injury and hepatocarcinogenesis. Biochemistry and Cell Biology 2019; 97(2) doi: 10.1139/bcb-2017-0321
|
| 41 |
Nathalie Mentha, Sophie Clément, Francesco Negro, Dulce Alfaiate. A review on hepatitis D: From virology to new therapies. Journal of Advanced Research 2019; 17 doi: 10.1016/j.jare.2019.03.009
|
| 42 |
Tyng-Yuan Jang, Yu-Ju Wei, Ming-Lun Yeh, Shu-Fen Liu, Cheng-Ting Hsu, Po-Yao Hsu, Ta-Wei Liu, Yi-Hung Lin, Po-Cheng Liang, Meng-Hsuan Hsieh, Yu-Min Ko, Yi-Shan Tsai, Kuan-Yu Chen, Ching-Chih Lin, Pei-Chien Tsai, Shu-Chi Wang, Ching-I. Huang, Zu-Yau Lin, Shinn-Cherng Chen, Wan-Long Chuang, Jee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, Ming-Lung Yu. Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues. Journal of the Formosan Medical Association 2021; 120(1) doi: 10.1016/j.jfma.2020.10.002
|
| 43 |
Анатолій Бондаренко. Застосування противірусних препаратів прямої дії проти гепатиту B при етіотропній терапії гепатиту дельта. Інфекційні хвороби 2026; (2) doi: 10.11603/1681-2727.2026.2.16506
|
| 44 |
Johanna Landahl, Jan Hendrik Bockmann, Christoph Scheurich, Christin Ackermann, Verena Matzat, Janna Heide, Tungalag Nuurei, Gianluca D’Antonio, Johann von Felden, Alessandro Sette, Sven Peine, Ansgar W Lohse, Marc Luetgehetmann, Matthias Marget, John Sidney, Julian Schulze zur Wiesch. Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II–Restricted, Hepatitis Delta Virus (HDV)–Specific T-Cell Responses Regardless of Clinical Status. The Journal of Infectious Diseases 2019; 219(4) doi: 10.1093/infdis/jiy549
|
| 45 |
Poonam Mathur, Arshi Khanam, Shyam Kottilil. Chronic Hepatitis D Virus Infection and Its Treatment: A Narrative Review. Microorganisms 2024; 12(11) doi: 10.3390/microorganisms12112177
|
| 46 |
|
| 47 |
|
| 48 |
Raisa Eloise Barbu, Mariana Daniela Ignat, Roxana Elena Bogdan Goroftei, Alexia Anastasia Ștefania Baltă, Valerii Lutenco, Valentin Bulza, Valerian Ionuț Stoian, Simona Claudia Cambrea, Elena Dumea, Liliana Baroiu. Clinical and Pathophysiological Considerations Related to the Impact of Bulevirtide, a New Entry Inhibitor, in HBV-HDV Infection. Viruses 2026; 18(4) doi: 10.3390/v18040477
|
| 49 |
Matthew August Odenwald, Sonali Paul. Viral hepatitis: Past, present, and future. World Journal of Gastroenterology 2022; 28(14): 1405-1429 doi: 10.3748/wjg.v28.i14.1405
|
| 50 |
Kuihao Chen, Zhe Gao. Acacetin, a Natural Flavone with Potential in Improving Liver Disease Based on Its Anti-Inflammation, Anti-Cancer, Anti-Infection and Other Effects. Molecules 2024; 29(20) doi: 10.3390/molecules29204872
|
| 51 |
Zhimin Guo, Thomas King. Therapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus Infection. International Journal of Molecular Sciences 2015; 16(8) doi: 10.3390/ijms160819537
|
| 52 |
Luna Colagrossi, Romina Salpini, Rossana Scutari, Luca Carioti, Arianna Battisti, Lorenzo Piermatteo, Ada Bertoli, Lavinia Fabeni, Carmine Minichini, Pascale Trimoulet, Hervé Fleury, Elena Nebuloso, Maria De Cristofaro, Giuseppina Cappiello, Alberto Spanò, Vincenzo Malagnino, Terenzio Mari, Angelo Barlattani, Nerio Iapadre, Miriam Lichtner, Claudio Mastroianni, Ilaria Lenci, Caterina Pasquazzi, Giuseppe De Sanctis, Alfonso Galeota Lanza, Maria Stanzione, Gianfranca Stornaiuolo, Massimo Marignani, Loredana Sarmati, Massimo Andreoni, Mario Angelico, Francesca Ceccherini-Silberstein, Carlo-Federico Perno, Nicola Coppola, Valentina Svicher. HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets. Viruses 2018; 10(7) doi: 10.3390/v10070363
|
| 53 |
E. Shirvani-Dastgerdi, S. Amini-Bavil-Olyaee, S. Moayed Alavian, C. Trautwein, F. Tacke. Comprehensive analysis of mutations in the hepatitis delta virus genome based on full-length sequencing in a nationwide cohort study and evolutionary pattern during disease progression. Clinical Microbiology and Infection 2015; 21(5) doi: 10.1016/j.cmi.2014.12.008
|
| 54 |
Bhavana Tetali, Brianna Kuperus, Nikhilesh Mazumder. Identifying and Screening At-Risk Patients for Hepatitis Delta Virus: A Case Report. Cureus 2023; doi: 10.7759/cureus.33660
|
| 55 |
Christopher Koh, Theo Heller, Jeffrey S. Glenn. Pathogenesis of and New Therapies for Hepatitis D. Gastroenterology 2019; 156(2) doi: 10.1053/j.gastro.2018.09.058
|
| 56 |
Yukihiro Nakanishi, Romil Saxena. Essentials of Anatomic Pathology. 2016; doi: 10.1007/978-3-319-23380-2_44
|
| 57 |
|
| 58 |
Shibin Qu, Xisheng Yang, Xiaolei Li, Jianlin Wang, Yuan Gao, Runze Shang, Wei Sun, Kefeng Dou, Haimin Li. Circular RNA: A new star of noncoding RNAs. Cancer Letters 2015; 365(2) doi: 10.1016/j.canlet.2015.06.003
|
| 59 |
I. P. Balmasova, R. I. Sepiashvili, T. A. Slavyanskaya, E. S. Malova, Ya. R. Sepiashvili. COINFECTION BY HEPATITIS B AND HEPATITIS DELTA VIRUSES: MOLECULAR BIOLOGY OF PATHOGENS AND PROSPECTS OF PHARMACOTHERAPY. Journal of microbiology, epidemiology and immunobiology 2018; 95(2) doi: 10.36233/0372-9311-2018-2-95-102
|
| 60 |
Nicola Coppola, Loredana Alessio, Lorenzo Onorato, Caterina Sagnelli, Evangelista Sagnelli, Mariantonietta Pisaturo. HDV infection in immigrant populations. Journal of Medical Virology 2019; 91(12) doi: 10.1002/jmv.25570
|
| 61 |
Luciana Costa Faria, Débora Raquel Benedita Terrabuio, Hakan Leblebicioglu, Shirish Huprikar. Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors. Transplantation 2018; 102(2S) doi: 10.1097/TP.0000000000002013
|
| 62 |
Yeshambel Belyhun, Uwe Gerd Liebert, Melanie Maier. Clade homogeneity and low rate of delta virus despite hyperendemicity of hepatitis B virus in Ethiopia. Virology Journal 2017; 14(1) doi: 10.1186/s12985-017-0844-z
|
| 63 |
Castine Bernardy, James Malley. Virus Behavior after UV254 Treatment of Materials with Different Surface Properties. Microorganisms 2023; 11(9) doi: 10.3390/microorganisms11092157
|
| 64 |
Lennart Hermanussen, Sibylle Lampalzer, Jan-Hendrik Bockmann, Annerose E. Ziegler, Felix Piecha, Maura Dandri, Sven Pischke, Friedrich Haag, Ansgar W. Lohse, Marc Lütgehetmann, Christina Weiler-Normann, Julian Schulze zur Wiesch. Non-organ-specific autoantibodies with unspecific patterns are a frequent para-infectious feature of chronic hepatitis D. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1169096
|
| 65 |
Emuejevuoke Umukoro, Joseph J. Alukal, Kevin Pak, Julio Gutierrez. State of the Art. Clinics in Liver Disease 2023; 27(4) doi: 10.1016/j.cld.2023.05.008
|
| 66 |
Zaigham Abbas, Minaam Abbas. Serum cholinesterase: A predictive biomarker of hepatic reserves in chronic hepatitis D. World Journal of Hepatology 2017; 9(22): 967-972 doi: 10.4254/wjh.v9.i22.967
|